BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
11 results:

  • 1. Uveal melanoma: In the era of new treatments.
    Wespiser M; Neidhardt E; Negrier S
    Cancer Treat Rev; 2023 Sep; 119():102599. PubMed ID: 37473516
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.
    Yang F; Zheng X; Koh S; Lu J; Cheng J; Li P; Du C; Chen Y; Chen X; Yang L; Chen W; Wong RW; Wai LE; Wang T; Zhang Q; Chen W
    Hepatol Int; 2023 Aug; 17(4):850-859. PubMed ID: 37067675
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tebentafusp for the treatment of hla-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
    Chen LN; Carvajal RD
    Expert Rev Anticancer Ther; 2022 Oct; 22(10):1017-1027. PubMed ID: 36102132
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive liver cancer Based on a Balance of Risk and Benefit.
    Luo X; Cui H; Cai L; Zhu W; Yang WC; Patrick M; Zhu S; Huang J; Yao X; Yao Y; He Y; Ji Y
    Front Immunol; 2020; 11():623. PubMed ID: 32425926
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anterior gradient 2-derived peptide upregulates major histocompatibility complex class I-related chains A/B in hepatocellular carcinoma cells.
    Bian J; He L; Wu Y; Liu W; Ma H; Sun M; Yu J; Yu Z; Wei M
    Life Sci; 2020 Apr; 246():117396. PubMed ID: 32035130
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive liver cancer.
    Docta RY; Ferronha T; Sanderson JP; Weissensteiner T; Pope GR; Bennett AD; Pumphrey NJ; Ferjentsik Z; Quinn LL; Wiedermann GE; Anderson VE; Saini M; Maroto M; Norry E; Gerry AB
    Hepatology; 2019 May; 69(5):2061-2075. PubMed ID: 30561769
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
    Lv X; Ye G; Zhang X; Huang T
    Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.
    Turcotte S; Katz SC; Shia J; Jarnagin WR; Kingham TP; Allen PJ; Fong Y; D'Angelica MI; DeMatteo RP
    Cancer Immunol Res; 2014 Jun; 2(6):530-7. PubMed ID: 24894090
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
    Akiyama Y; Oshita C; Kume A; Iizuka A; Miyata H; Komiyama M; Ashizawa T; Yagoto M; Abe Y; Mitsuya K; Watanabe R; Sugino T; Yamaguchi K; Nakasu Y
    BMC Cancer; 2012 Dec; 12():623. PubMed ID: 23270484
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Evaluation of a new, microfluidic chip-based immunoassay for measurement of AFP-L3].
    Sato S; Toyota J; Kagebayashi C; Kurosawa T; Watanabe M; Satomura S
    Rinsho Byori; 2010 Dec; 58(12):1155-61. PubMed ID: 21348234
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Distant metastases in ovarian carcinoma.
    Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
    Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.